SAIT - Specific Active immunotherapy (SAIT) against PCSK9 is safe and lowers circulating LDL-C in humans

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Late Breaking Pharmacological Science Lipid-Lowering Agents ESC Premium Access ESC Congress 2018

ESC 365 is supported by

ESC 365 is supported by